Felodipine and Hepatotoxicity - a phase IV clinical study of FDA data

Summary:

Hepatotoxicity is reported as a side effect among people who take Felodipine (felodipine), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Atenolol, and have Urinary tract infection.

The phase IV clinical study analyzes which people have Hepatotoxicity when taking Felodipine. It is created by eHealthMe based on reports of 14,707 people who have side effects when taking Felodipine from the FDA, and is updated regularly.

What is Felodipine?

Felodipine has active ingredients of felodipine. It is often used in high blood pressure. eHealthMe is studying from 15,120 Felodipine users. Check the latest studies of Felodipine.

What is Hepatotoxicity?

Hepatotoxicity (chemical-driven liver damage) is found to be associated with 1,081 drugs and 1,249 conditions by eHealthMe. Check the latest studies of Hepatotoxicity.

On Aug, 03, 2026

14,707 people reported to have side effects when taking Felodipine.
Among them, 22 people (0.15%) have Hepatotoxicity.

Among these 22 people:

How long have people been on Felodipine when they have Hepatotoxicity? *

What is the gender of people who have Hepatotoxicity when taking Felodipine? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Hepatotoxicity when taking Felodipine? *

What are other drugs people take besides Felodipine? *

What are other side effects people have besides Hepatotoxicity? *

Dementia (madness): 5 people, 22.73%
Fall: 5 people, 22.73%
Antinuclear Antibody Positive: 5 people, 22.73%
Alanine Aminotransferase Increased: 4 people, 18.18%
Gamma-Glutamyltransferase Increased: 4 people, 18.18%
Aspartate Aminotransferase Increased: 4 people, 18.18%
Confusional State: 4 people, 18.18%
Blood Bilirubin Increased: 4 people, 18.18%
Fatigue (feeling of tiredness): 3 people, 13.64%
Constipation: 3 people, 13.64%

What are the existing conditions these people have? *

Urinary Tract Infection: 4 people, 18.18%
Hepatitis C: 3 people, 13.64%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 3 people, 13.64%
Insomnia (sleeplessness): 2 people, 9.09%
Eye Pruritus (eye itching): 2 people, 9.09%
Fatigue (feeling of tiredness): 2 people, 9.09%
Haemoglobin Decreased: 2 people, 9.09%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 9.09%
Lacrimation Increased: 2 people, 9.09%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Felodipine and have Hepatotoxicity?

- Check whether Hepatotoxicity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Felodipine:

Felodipine (15,120 reports)

Hepatotoxicity treatments and more:

Hepatotoxicity (23,823 reports)

Browse all side effects of Felodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatotoxicity:

Hepatotoxicity (1,081 drugs)

Browse all the conditions that are associated with Hepatotoxicity:

Hepatotoxicity (1,249 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on felodipine (the active ingredients of Felodipine) and Felodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.